By GREGORY ZELLER // The National Institutes of Health has welcomed a rising Stony Brook biotech into its competitive Commercialization Accelerator Program. Traverse Biosciences, which is attempting to commercialize novel…
By GREGORY ZELLER // When a new U.S. patent is your second-biggest announcement of the day, you’re probably in a good place. It’s all smiles (with healthy teeth, of course)…
By GREGORY ZELLER // It seems everyone wants a piece of TRB-N0224. Already being tested as a potential treatment for lung injuries and for periodontal disease in dogs and cats,…
Stony Brook-based biotech Traverse Biosciences will share a Department of Defense award with SUNY Upstate Medical University to fund a critical field test of Traverse’s leading drug candidate. The effectiveness…